Back
Structure Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41
GPCR
Structure Therapeutics
Last Price:
$23.85
Seasonality Move:
-1.69%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.93 | Sell |
| 20-day SMA: | 24.37 | Sell |
| 50-day SMA: | 21.33 | Buy |
| 200-day SMA: | 30.76 | Sell |
| 8-day EMA: | 25.28 | Sell |
| 20-day EMA: | 24.14 | Sell |
| 50-day EMA: | 23.07 | Buy |
| 200-day EMA: | 28.9 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.42 | Buy |
| Relative Strength Index (14 RSI): | 51.49 | Buy |
| Chaikin Money Flow: | -788912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.53 - 26.81) | Buy |
| Bollinger Bands (100): | (19.79 - 28.23) | Sell |
Structure Therapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 23.89 while GPCR 8-day simple moving average is 25.93, which is a Sell signal.
-
The stock price of GPCR is 23.89 while Structure Therapeutics 20-day SMA is 24.37, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 21.33 while GPCR share price is 23.89, making it a Buy technically.
-
GPCR stock price is 23.89 and Structure Therapeutics 200-day simple moving average is 30.76, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
41
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $23.89. The Score for GPCR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
23.89
Share Volume:
840.9K
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
13.22
Sell
41
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 23.89 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 23.89 while GPCR 8-day exponential moving average is 25.28, which is a Sell signal.
-
The stock price of GPCR is 23.89 while Structure Therapeutics 20-day EMA is 24.14, which makes it a Sell.
-
Structure Therapeutics 50-day exponential moving average is 23.07 while GPCR share price is 23.89, making it a Buy technically.
-
GPCR stock price is 23.89 and Structure Therapeutics 200-day simple moving average is 28.90, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 1.42, suggesting Structure Therapeutics is a Buy
-
Structure Therapeutics Relative Strength Index (RSI) is 51.49, which suggest Structure Therapeutics is overbought
-
The Bollinger Bands (25) for Structure Therapeutics is (18.53 - 26.81), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (19.79 - 28.23), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.